GIP
SUPN icon

Granite Investment Partners’s Supernus Pharmaceuticals SUPN Stock Holding History

Granite Investment Partners’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-338,701
Closed -$13.5M – 315
2017
Q4 		$13.5M Sell
338,701
-32,453
-9% -$1.28M 0.85% 40
2017
Q3 		$14.8M Sell
371,154
-111,808
-23% -$4.84M 0.92% 36
2017
Q2 		$20.8M Buy
482,962
+12,163
+3% +$433K 1.4% 5
2017
Q1 		$14.7M Buy
470,799
+43,967
+10% +$1.18M 1.01% 17
2016
Q4 		$10.8M Sell
426,832
-13,939
-3% -$311K 0.79% 42
2016
Q3 		$10.9M Sell
440,771
-86,399
-16% -$1.96M 0.81% 28
2016
Q2 		$10.7M Buy
527,170
+187,670
+55% +$3.33M 0.85% 31
2016
Q1 		$5.18M Buy
339,500
+272,923
+410% +$3.56M 0.47% 89
2015
Q4 		$895K Sell
66,577
-7,157
-10% -$111K 0.08% 236
2015
Q3 		$1.03M Sell
73,734
-33,573
-31% -$624K 0.1% 218
2015
Q2 		$1.82M Sell
107,307
-27,089
-20% -$386K 0.17% 159
2015
Q1 		$1.63M Buy
134,396
+35,230
+36% +$333K 0.14% 179
2014
Q4 		$823K Buy
99,166
+58,275
+143% +$490K 0.09% 241
2014
Q3 		$355K Buy
40,891
+1,085
+3% +$9.8K 0.05% 249
2014
Q2 		$436K Buy
39,806
+539
+1% +$4.8K 0.06% 221
2014
Q1 		$351K Buy
+39,267
New +$362K 0.05% 206

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Granite Investment Partners's SUPN Position: Q1 2018 in Review

Granite Investment Partners sold out of Supernus Pharmaceuticals (SUPN) in Q1 2018, closing a stake of 338,701 shares — an estimated $13.5M sold.

Granite Investment Partners first reported a position in SUPN in Q1 2014 and held it in 16 quarters. The position peaked at $20.8M in Q2 2017. 312 funds tracked by Wall St. Rank hold SUPN as of Q1 2018.

  • Granite Investment Partners reported no remaining Supernus Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Granite Investment Partners sold 338,701 Supernus Pharmaceuticals shares in Q1 2018, an estimated $13.5M.
  • Granite Investment Partners first reported a position in Supernus Pharmaceuticals in Q1 2014 and held it in 16 quarters.
  • Granite Investment Partners's Supernus Pharmaceuticals position peaked at $20.8M in Q2 2017.
  • 312 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2018.

Based on Granite Investment Partners's 13F filing for Q1 2018, filed 4 May 2018.